Literature DB >> 8442812

Risk factors and deliveries associated with preterm, severely small for gestational age fetuses.

P Palo1, R Erkkola.   

Abstract

Maternal and fetal risk factors and deliveries associated with 153 singleton, preterm, severely small for gestational age (SGA) fetuses were compared to the corresponding data of 153 next-born preterm appropriate for gestational age (AGA) fetuses matched for gestational age. Maternal history of previous delivery of an infant of SGA status, pre-eclampsia, hypertension without proteinuria, oligohydramnios, and fetal congenital anomalies were identified as risk factors for preterm, severely SGA deliveries. In the preterm, severely SGA group the rate for abdominal deliveries was 82%. Of these operations, 40% were emergency cesarean sections, many of which involved pre-eclampsia cases. If congenital malformations were excluded, perinatal mortality rate was 7% in the preterm SGA group and 4.6% in the preterm AGA group. Preterm, severely SGA fetuses constitute a perinatal risk group, which cannot be avoided. However, awareness of and familiarity with the risk factors associated with preterm, severely SGA cases can better equip the attending physician to consider appropriate perinatal care options.

Entities:  

Mesh:

Year:  1993        PMID: 8442812     DOI: 10.1055/s-2007-994712

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

1.  Employment, job strain, and preterm delivery among women in North Carolina.

Authors:  K M Brett; D S Strogatz; D A Savitz
Journal:  Am J Public Health       Date:  1997-02       Impact factor: 9.308

2.  The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity.

Authors:  Joao Guilherme B Alves; Carla Adriane Fonseca Leal de Araújo; Isabelle E A Pontes; Angélica C Guimarães; Joel G Ray
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-08       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.